Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2025-12-24 @ 9:16 PM
NCT ID:
NCT02583204
Eligibility Criteria:
Inclusion Criteria:
* women over the age of 18 years who have been diagnosed with a breast cancer.
* must be receiving adjuvant or neo-adjuvant Taxotere chemotherapy for breast cancer.
* participants must be fluent English speakers to be eligible to take part, as there are no resources or additional funding for translators or interpreting services.
* Participants must provide informed consent.
Exclusion Criteria:
* Male patients with a diagnosis of breast cancer
* Patients who are non-fluent English speakers
* Patients with a known hypersensitivity reaction to nail/ relevant cosmetic products
* Previous treatment with taxane chemotherapy with the last two years
* Patients with only one upper limb.
* Patients with a neurological deficit to the upper limb (eg, stroke affecting one side)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02583204
Study Brief:
Protocol Section:
NCT02583204